| [1] | Infectious Diseases Physicians Branch， Chinese Medical Doctor Association, Chinese Society of Infectious Diseases， Chinese Medical Association. Chinese practice guideline for the prevention and treatment of mother-to-child transmission of hepatitis B virus （version 2024）[J]. Journal of Clinical Hepatology, 2024, 40(8): 1557-1566. doi: 10.12449/JCH240809 |
| [2] | Jianing KONG, Binbin ZHANG, Junping SHI. An excerpt of clinical practice guideline of prevention and treatment of metabolic dysfunction-associated （non-alcoholic） fatty liver disease （2024 edition）[J]. Journal of Clinical Hepatology, 2024, 40(9): 1767-1770. doi: 10.12449/JCH240908 |
| [3] | Liver Failure and Artificial Liver Group， Chinese Society of Infectious Diseases， Chinese Medical Association, Severe Liver Disease and Artificial Liver Group， Chinese Society of Hepatology， Chinese Medical Association. Guideline for diagnosis and treatment of liver failure （2024 version）[J]. Journal of Clinical Hepatology, 2024, 40(12): 2371-2387. doi: 10.12449/JCH241206 |
| [4] | Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Disease and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. Guideline for diagnosis and treatment of liver failure(2018)[J]. Journal of Clinical Hepatology, 2019, 35(1): 38-44. doi: 10.3969/j.issn.1001-5256.2019.01.007 |
| [5] | Dai MingJia, Leng XueJun, Yan XueBing. Interpretation of 2015 WHO guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection: comparison antiviral treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2015, 31(7): 1004-1007. doi: 10.3969/j.issn.1001-5256.2015.07.003 |
| [6] | Expert Committee for Antiviral Therapy for Special Patients with Chronic Hepatitis B;. Expert consensus on antiviral therapy for special patients with chronic hepatitis B: an update in 2015[J]. Journal of Clinical Hepatology, 2015, 31(8): 1185-1192. doi: 10.3969/j.issn.1001-5256.2015.08.002 |
| [7] | Group of Pancreas Surgery, Chinese Society of Surgery, Chinese Medical Associati. Guidelines for the management of pancreatic cystic lesions(2015)[J]. Journal of Clinical Hepatology, 2015, 31(9): 1375-1378. doi: 10.3969/j.issn.1001-5256.2015.09.003 |
| [8] | Yu yueCheng, Hou JinLin. An excerpt of treatment algorithm for the management of chronic hepatitis B virus infection in the United States: 2015 update[J]. Journal of Clinical Hepatology, 2015, 31(11): 1782-1790. doi: 10.3969/j.issn.1001-5256.2015.11.005 |
| [9] | Chinese Society of Hepatology and Chinese Society of Infectious Diseases, Chinese Medical Association . The guideline of prevention and treatment for chronic hepatitis B: a 2015 update[J]. Journal of Clinical Hepatology, 2015, 31(12): 1941-1960. doi: 10.3969/j.issn.1001-5256.2015.12.002 |
| [10] | Obstetrics Subgroup, Chinese Society of Obstetrics and Gynecology, Chinese Medical Association. Guidelines for the management of intrahepatic cholestasis of pregnancy (2015)[J]. Journal of Clinical Hepatology, 2015, 31(10): 1575-1578. doi: 10.3969/j.issn.1001-5256.2015.10.003 |
| [11] | Drug-induced Liver Disease Study Group, Chinese Society of Hepatology, Chinese Medical Association. Guidelines for the management of drug-induced liver injury[J]. Journal of Clinical Hepatology, 2015, 31(11): 1752-1769. doi: 10.3969/j.issn.1001-5256.2015.11.002 |
| [12] | Group of Pancreas Surgery, Chinese Society of Surgery, Chinese Medical Association. Guidelines for the management of chronic pancreatitis(2014)[J]. Journal of Clinical Hepatology, 2015, 31(3): 322-326. doi: 10.3969/j.issn.1001-5256.2015.03.002 |
| [13] | Experts attending the discussion on long-treatment of chronic hepatitis B. Long-term treatment of chronic hepatitis B[J]. Journal of Clinical Hepatology, 2014, 30(11): 1099-1105. doi: 10.3969/j.issn.1001-5256.2014.11.002 |
| [14] | Group of Pancreas Surgery, Chinese Society of Surgery, Chinese Medical Association. Guidelines for the management of pancreatic neuroendocrine neoplasms (2014)[J]. Journal of Clinical Hepatology, 2014, 30(12): 1246-1248. doi: 10.3969/j.issn.1001-5256.2014.12.004 |
| [15] | Yan Jie, Xie Wen. Expert consenus on antiviral therapy for special patients with chronic hepatitis B: an update in 2014[J]. Journal of Clinical Hepatology, 2014, 30(7): 580-587. doi: 10.3969/j.issn.1001-5256.2014.07.002 |
| [16] | Pancreas Study Group, Chinese Society of Gastroenterology, Chinese Medical Association, Editorial Board of Chinese Journal of Pancreatology, Editorial Board of Chinese Journal of Digestion. Chinese guidelines for the management of acute pancreatitis ( Shanghai, 2013)[J]. Journal of Clinical Hepatology, 2013, 29(9): 656-660. doi: 10.3969/j.issn.1001-5256.2013.09.006 |
| [17] | Fan Rong, Liang XieEr, Sun Jian, Hou JinLin. Explanation of the “Asian-Pacific consensus statement on the management of chronic hepatitis B: A 2012 update”: Treatment strategy, resistance management and non-invasive evalution of liver fibrosis[J]. Journal of Clinical Hepatology, 2012, 28(7): 484-486. |
| [18] | Yang Song, Cheng Jun. Interpretation of Chinese guideline on prevention and treatment for chronic hepatitis B (2011version) -status quo and prospect of antiviral therapy[J]. Journal of Clinical Hepatology, 2011, 27(8): 794-795+800. |
| [19] | Li Hai, Jia JiDong. Interpretation of the guideline on prevention and treatment for chronic hepatitis B (2010 version) -the goals and indications for chronic hepatitis B treatment[J]. Journal of Clinical Hepatology, 2011, 27(8): 791-793. |
| [20] | Jia JiDong, Li LanJuan. The guideline of prevention and treatment for chronic hepatitis B(2010 version)[J]. Journal of Clinical Hepatology, 2011, 27(1): 113-128. |
DownLoad: